Health & Fitness
BRENTWOOD, N.Y.--([ BUSINESS WIRE ])--Medical Action Industries Inc. (NASDAQ: MDCI), announced today that it will hold a conference call to present its financial results for the quarter and year ended March 31, 2012 on June 14, 2012 at 10:00 a.m. (ET).
Paul D. Meringolo, Medical Actionas President and CEO further advised that our results of operations for the quarter ended March 31, 2012 are scheduled to be released on Thursday, June 14, 2012 before the market opens. The conference call will be conducted by Mr. Meringolo, Mr. John Sheffield, Chief Financial Officer and Mr. Brian Baker, Corporate Controller.
The conference call will be simultaneously webcast on our website: [ www.medical-action.com ]. The dial-in number for the conference call is (877) 637-9564 (domestic) or (973) 935-8511 (international); conference ID #89890094. The complete call and discussion will be available for replay on our website beginning at 1:00 p.m. (ET) on June 14, 2012.
Medical Action is a diversified manufacturer and distributor of disposable medical devices and a leader in many of the markets where it competes. Its products are marketed primarily to acute care facilities in domestic and certain international markets. The Company has expanded its target market to include physician, dental and veterinary office, out-patient surgery centers, long-term care facilities and laboratories. Medical Actionas products are marketed nationally by its direct sales personnel and extensive network of healthcare distributors. The Company has preferred vendor agreements with national and regional distributors, as well as sole and multi-source agreements with group purchasing organizations. Medical Actionas common stock trades on the NASDAQ Global Select Market under the symbol MDCI and is included in the Russell 2000 Index.
This news release contains forward-looking statements that involve risks and uncertainties regarding Medical Actionas operations and future results.Please see the Companyas filings with the Securities and Exchange Commission, including, without limitation, the Companyas Form 10-K and Form 10-Qs, which identify specific factors that would cause actual results or events to differ materially from those described in the forward-looking statements.